Welcome Center  |   Log In  |   Register  |   Follow Us  Facebook  Twitter Google Plus

Latest in Pulmonary Medicine

Reuters Health • The Doctor's Channel Daily Newscast

Dyspnea common with ticagrelor antiplatelet therapy

NEW YORK (Reuters Health) – Episodes of dyspnea are more common in patients treated with the antiplatelet agent than in those taking clopidogrel, although the clinical importance of this side effect seems minor in most cases. Ticagrelor is a reversible...
NEW YORK (Reuters Health) – Azithromycin is not only an effective treatment for bronchiolitis obliterans syndrome (BOS) that occurs in many lung transplant patients, it can also prevent the condition developing, a Belgian team reports in the European...

Reuters Health • The Doctor's Channel Daily Newscast

Progression of EGFR-mutated lung cancer slowed with first-line gefitinib

NEW YORK (Reuters Health) – Patients with non-small-cell lung cancer harboring susceptibility mutations in the epidermal growth factor receptor (EGFR) did better with gefitinib given as first-line therapy than with standard chemotherapy, in a randomized...